Virtu Financial’s Psyence Biomedical PBM Stock Holding History

Virtu Financial’s Portfolio PBM Stock Details PBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,927	Closed	-$28K	–	2401
2025 Q4	$28K	Buy	5,927 +4,275	+259%	+$63.7K	﹤0.01%	1375
2025 Q3	$33K	Buy	+1,652	New	+$45.4K	﹤0.01%	1212
2025 Q2	–	Sell	-732	Closed	-$22K	–	2108
2025 Q1	$22K	Buy	732 +477	+187%	+$30.3K	﹤0.01%	1097
2024 Q4	$27K	Buy	+255	New	+$60.8K	﹤0.01%	1254
2024 Q3	–	Sell	-4	Closed	-$4K	–	1962
2024 Q2	$4K	Sell	4 -3	-43%	-$8.99K	﹤0.01%	1192
2024 Q1	$30K	Buy	+7	New	+$29.2K	﹤0.01%	1107

Other funds holding PBM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

Virtu Financial's PBM Position: Q1 2026 in Review

Virtu Financial sold out of Psyence Biomedical (PBM) in Q1 2026, closing a stake of 5,927 shares — an estimated $28K sold.

Virtu Financial first reported a position in PBM in Q1 2024 and held it in 6 quarters. The position peaked at $33K in Q3 2025. 2 funds tracked by Wall St. Rank hold PBM as of Q1 2026.

Virtu Financial reported no remaining Psyence Biomedical position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 5,927 Psyence Biomedical shares in Q1 2026, an estimated $28K.
Virtu Financial first reported a position in Psyence Biomedical in Q1 2024 and held it in 6 quarters.
Virtu Financial's Psyence Biomedical position peaked at $33K in Q3 2025.
2 funds tracked by Wall St. Rank held Psyence Biomedical as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.